Invention Grant
- Patent Title: In vivo detection of EGFR mutation in glioblastoma via MRI signature consistent with deep peritumoral infiltration
-
Application No.: US15493722Application Date: 2017-04-21
-
Publication No.: US11107217B2Publication Date: 2021-08-31
- Inventor: Donald O'Rourke , Spyridon Bakas , Christos Davatzikos
- Applicant: The Trustees of the University of Pennsylvania
- Applicant Address: US PA Philadelphia
- Assignee: The Trustees of the University of Pennsylvania
- Current Assignee: The Trustees of the University of Pennsylvania
- Current Assignee Address: US PA Philadelphia
- Agency: Howson & Howson LLP
- Agent Cathy A. Kodroff
- Main IPC: G06T7/00
- IPC: G06T7/00

Abstract:
A method, including a computer-implemented method, is provided for in vivo detection of epidermal growth factor receptor (EGFR) mutation status within peritumoral edematous tissue of a patient. The method includes performing quantitative pattern analysis of magnetic resonance imaging (MRI) data corresponding to MRI of in vivo peritumoral edematous tissue to determine a level of spatial heterogeneity or similarity within the in vivo peritumoral edematous tissue. EGFR mutation status is assigned as one of negative or positive based on the level of spatial heterogeneity or similarity determined. A non-transitory computer-readable storage medium and a system are also provided.
Public/Granted literature
Information query